公开(公告)号：KR101095401B1

公开(公告)日：2011-12-16

申请号：KR1020110036682

申请日：2011-04-20

Applicant: 강원대학교산학협력단

Inventor： 정두일 ,  김경종 ,  백남인 ,  류현열 ,  박해니

IPC: A61K31/352 ,  A61K31/353 ,  A61P17/00 ,  A61P27/14

Abstract: PURPOSE: A composition containing eupatilin for treating allergic diseases is provided to suppress reactive oxygen species(ROS) and phox gene expression. CONSTITUTION: A pharmaceutical composition for preventing and treating allergic disorder contains 10-1000ug/ml of eupatilin as an active ingredient. The eupatilin is isolated from Artemisia asiatica Nakai. The allergic disorders are atopic dermatitis, hives, or allergic rhinitis. A cosmetic composition for preventing and treating allergic disorder contains 10-1000 ug/ml of eupatilin as an active ingredient.

Abstract translation: 目的：提供含有用于治疗过敏性疾病的醋酸蛋白酶的组合物，以抑制活性氧（ROS）和phox基因表达。 构成：用于预防和治疗过敏性疾病的药物组合物含有10-1000ug / ml的作为活性成分的胡萝卜素。 艾蒿素是从艾蒿（Asematica Nakai）中分离出来的。 过敏性疾病是特应性皮炎，荨麻疹或过敏性鼻炎。 用于预防和治疗过敏性疾病的化妆品组合物含有10-1000ug / ml的作为活性成分的依帕替林。